Ana María Pello

Learn More
Patients with symptomatic aortic stenosis have a very poor prognosis on medical treatment. In those with contraindications to surgery, percutaneous valve replacement has been proposed as an alternative. We report on physicians' initial experience in Spain with percutaneous aortic valve replacement. We analyzed inhospital and short-to-medium-term findings in(More)
OBJECTIVES To study the prognostic value of high-sensitive troponin (hs-cTn) I in stable coronary artery disease. METHODS In total, we studied 705 patients. Secondary outcomes were the incidence of: (1) acute ischemic events and (2) heart failure or death. The primary outcome was the composite of them. RESULTS Patients with hs-cTnI >0 ng/ml (62.1%) were(More)
OBJECTIVE Vitamin D and fibroblast growth factor-23 (FGF-23) are related with cardiovascular disorders. We have investigated the relationship of calcidiol (vitamin D metabolite) and FGF-23 plasma levels with the incidence of adverse outcomes in patients with coronary artery disease. METHODS Prospective follow-up study of 704 outpatients, attending the(More)
BACKGROUND AND OBJECTIVES We investigated the relationship of the Syntax Score (SS) and coronary artery calcification (CAC), with plasma levels of biomarkers related to cardiovascular damage and mineral metabolism, as there is sparse information in this field. METHODS We studied 270 patients with coronary disease that had an acute coronary syndrome (ACS)(More)
OBJECTIVE Several papers have reported elevated plasma levels of natriuretic peptides in patients with a previous diagnosis of cancer. We have explored whether N-terminal pro-brain natriuretic peptide (NT-proBNP) plasma levels predict a future diagnosis of cancer in patients with coronary artery disease (CAD). METHODS We studied 699 patients with CAD free(More)
INTRODUCTION Decreased plasma vitamin D (VD) levels are linked to cardiovascular damage. However, clinical trials have not demonstrated a benefit of VD supplements on left ventricular (LV) remodelling. Anterior ST-elevation acute myocardial infarction (STEMI) is the best human model to study the effect of treatments on LV remodelling. We present a(More)
  • 1